REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto De Cancerologia De Sucre S.A.S. (Colombia)

Main Activities: General Medical and Surgical Hospitals
Full name: Instituto De Cancerologia De Sucre S.A.S. Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Instituto De Cancerologia De Sucre S.A.S. is based in Colombia. The head office is in Sincelejo. It operates in the General Medical and Surgical Hospitals industry. It was established on September 08, 1999. The latest financial highlights indicate a net sales revenue increase of 35.94% in 2023. Its’ total assets recorded a growth of 26.79%. The net profit margin of Instituto De Cancerologia De Sucre S.A.S. increased by 4.07% in 2023.

Headquarters
Cr 22 18 123
Sincelejo; Sucre;

Contact Details: Purchase the Instituto De Cancerologia De Sucre S.A.S. report to view the information.

Website: https://www.incans.com.co/

Basic Information
Outstanding Shares:
Purchase the Instituto De Cancerologia De Sucre S.A.S. report to view the information.
Incorporation Date:
September 08, 1999
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto De Cancerologia De Sucre S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
35.94%
Total operating revenue
35.94%
Operating profit (EBIT)
50.52%
EBITDA
23.65%
Net Profit (Loss) for the Period
73.28%
Total assets
26.79%
Total equity
54.77%
Operating Profit Margin (ROS)
3.34%
Net Profit Margin
4.07%
Return on Equity (ROE)
3.97%
Debt to Equity Ratio
-21.85%
Quick Ratio
0.1%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?